Trial intelligence / Profile preview

The Effect of Gluma and Bioactive Glass in Treatment of Dentin Hypersensitivity in Cervical Lesions

NCT07063433Completed

Sponsor
The British University in Egypt
Start
Feb 2025
Primary completion
May 2025
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

Randomised trial of Gluma Desensitizer in dentin hypersensitivity (DH) (4 arms), sponsored by The British University in Egypt. Primary endpoint: Visual Analog Scale at 6 months. Started Feb 2025; status: completed.

02

Drugs

Gluma Desensitizer
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT07063433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07063433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call